Attending the 2025 European Headache Congress? Heather Brown, Senior Editor @thelancetneuro.bsky.social, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BKqbs0

ICYMI: our December issue includes an overview of the evidence for blood and CSF biomarkers, including their potential clinical applications, in patients with multiple sclerosis. Read the Review by Tanuja Chitnis and colleagues here:
www.thelancet.com/journals/lan...

NEW ISSUE: Read the latest content on: Lewy bodies research, the global burden of headache disorders, brain amyloid and risk of cognitive impairment, biomarkers for multiple sclerosis, and more at:
thelancet.com/journals/lan...

Our October issue is out - featuring biomarkers for sudden unexpected death in epilepsy, developments in the diagnosis of multiple sclerosis, climate change & brain health and much more!

Check it out here: tinyurl.com/3z5u36e7

#Neurology #BrainHealth

NEW ISSUE ALERT!!🗞️🧠 Featuring physiotherapy after stroke, updates to the ILAE seizure classification, focused ultrasound therapy for movement disorders, α-synuclein biomarker assays, fenebrutinib in multiple sclerosis and much more: tinyurl.com/muj5ycp3
#Neurology #Brain

A pooled analysis of of the four INTERACT trials suggests intensive blood pressure-lowering initiated within several hours of intracerebral haemorrhage onset was safe and improved functional recovery, without a clear effect on haematoma growth. Check it out in our latest issue: tinyurl.com/mrnmv5f6

Are you ready for your research to spark global conversation? ✨ Begin your publication journey with us today and help to advance health and science worldwide.
hubs.li/Q03vpxN70

Congratulations to our authors and peer reviewers, whose expertise and hard work enable us to continuously publish some of the best science for better lives. This is as much your achievement!

Our recent issue features a thought insightful comment on the diagnostic and clinical potential of the α-synuclein seed amplification assay. Check it out here: tinyurl.com/2aaky4bx
#Parkinsons

#FriedreichsAtaxia is more than a rare neurological disease—it’s a multisystem disorder that affects the heart, metabolism, and muscles as well as the brain. This review spotlights new breakthroughs, including the 1st approved treatment, and highlights the need for more research tinyurl.com/zxpaef2b

Check out our July issue featuring blood pressure lowering after acute intracerebral haemorrhage, the potential of the α-synuclein seed amplification assay, cognitive decline in Down syndrome and more: tinyurl.com/3pvve45t

NEW ISSUE: Read the latest content on ischaemic stroke and transient ischaemic attack, amyotrophic lateral sclerosis, traumatic brain injury, Alzheimer's disease, CSF transport, Parkinson's disease and more at: thelancet.com/journals/lan...

Review content in the March issue:

📝 Enzyme replacement therapy for metabolic storage disorders
🧠 Strategies to cross the blood-brain barrier
🧬 The latest in our Series on genetic ALS, focusing on hexanucleotide repeat expansions in C9orf72

🖱️ www.thelancet.com/issue/S1474-...

Original research in the March issue:

🧠 Direct oral anticoagulants for cerebral venous thrombosis
💉 A meta-analysis of nerinetide for ischaemic stroke
🆕 A case series describing a new disease, autoinflammatory encephalopathy due to PTPN1 haploinsufficiency

🖱️ www.thelancet.com/issue/S1474-...

Our March issue is now live!

🖱️ You can read the latest content here: www.thelancet.com/issue/S1474-...

👂Listen to this month's podcast on neuroprotection in stroke: www.buzzsprout.com/1391383/epis...

✒️ Our Editorial this month is on the burden of encephalitis: www.thelancet.com/journals/lan...

The February 2025 issue of The Lancet Neurology is out now! www.thelancet.com/issue/S1474-...

Featuring content on myasthenia gravis, frontotemporal dementia, stroke, traumatic brain injury, and amyotrophic lateral sclerosis.